Greenville, SC – December 10, 2024 — Rymedi, a leader in clinical data management using blockchain technology, and Public Good Pharma (PGP) a financially-innovative biotech company established by Crowd Funded Cures, a registered charity and early DeSci pioneer, today announced a strategic partnership to revolutionize medicine accessibility.
Key Highlights of the Partnership:
- Clinical Data Management: Rymedi hosts clinical trial data on the blockchain for secure, auditable and immutable data handling, while ensuring compliance with data protection laws, including GDPR.
- Interventional Pharmacoeconomics – Self-Funding Trials: PGP introduces a groundbreaking approach to develop low-cost alternatives to expensive patented drugs without financial risk through self-funding “interventional pharmacoecononomic” (IVPE) trials funded by the cost-savings of health insurers.
- Data-Driven and Ethical Drug Development: By leveraging Rymedi’s blockchain solutions, PGP will enhance drug discovery, focusing on its pipeline of low-cost alternatives to high-cost specialty drugs causing significant financial toxicity in underserved communities.
- Global Health Initiatives: Together, the companies will work on initiatives aimed at improving healthcare infrastructure in low-resource settings, including working with Med Aditus Pharmaceuticals, who have established a state-of-the-art continuous flow pharmaceutical manufacturing plant in Kenya, supporting PGP’s mission to deliver affordable medications.
David Stefanich, CEO of Rymedi: “Our partnership with Public Good Pharma marks a significant step forward in our mission to secure and utilize blockchain for the greater good. By combining our technologies, we aim to set a new standard in healthcare delivery where innovation and ethics go hand in hand.”
Savva Kerdemelidis, Founder & CEO of Public Good Pharma and Crowd Funded Cures: “Working with Rymedi allows us to ensure that our focus on accessible, affordable medicine is backed by the best and most secure data practices. This partnership will help us bring critical treatments to those who need them most, faster and more safely than ever before.”
About Rymedi:
Rymedi is a technology company focused on enhancing healthcare through secure data management, analytics, and blockchain technology. Their solutions are designed to empower healthcare providers to deliver better patient outcomes while maintaining the highest standards of data integrity, security and privacy, fully-compliant with data protection regulations.
About Public Good Pharma:
Public Good Pharma is a financially-innovative biotech company established by the pioneering DeSci charity, Crowd Funded Cures, developing affordable therapies using self-funding interventional pharmacoeconomic (IVPE) clinical trials and Pay-for-Success (PFS) contracts that leverage the cost-savings of health insurers. Their mission is to address global health inequities by helping finance the development of low-cost therapies that are overlooked by traditional pharmaceutical companies, including repurposed generic drugs, biosimilars, nutraceuticals, diets, and behavioral interventions.
For more information, please contact:
Rymedi: info@rymedi.com (mailto:info@rymedi.com)
Public Good Pharma: info@publicgoodpharma.org (mailto:info@publicgoodpharma.org)
